Condition
CDH17-positive Advanced Solid Tumors clinical trials and research
As of November 12, 2026, Find a Trial lists 2 CDH17-positive Advanced Solid Tumors clinical trials that are recruiting, at sites in 2 countries (most in China (1), United States (1)). By phase: Early Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
BHB810 in advanced gastric and GEJ cancer (early-phase)
This study tests whether BHB810 can be safely given every two weeks to adults with advanced gastric or GEJ adenocarcinoma and looks at its effect, how the drug behaves in the body, and patient responses.
-
Evaluating a new CAR-T cell therapy for advanced solid tumors with CDH17 expression
This study is testing a new CAR-T cell therapy to see if it can help people with advanced solid tumors that have a specific marker called CDH17.
Related topics
Quick answers
How many CDH17-positive Advanced Solid Tumors clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.